Moderna, Inc.
Public company- Headquarters
- CAMBRIDGE, Massachusetts
- Industry
- Biotechnology
- Ticker
- MRNA
- CIK
- 0001682852
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| COOJuan Andres | Sep 30, 2026 | Appointed |
| Chief Technical Operations and Quality OfficerJerh Collins, Ph.D. | Sep 30, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Eloxx Pharmaceuticals, Inc.
director appointed: Geno J. Germano
- Voyager Therapeutics, Inc.
president appointed: Robin Swartz
- TScan Therapeutics, Inc.
Director departs: Garry Nicholson
- REPLIGEN CORP
Board of Directors departs: Karen A. Dawes
- Executive appointment
COO appointed: Juan Andres
Juan Andres was named Chief Operating Officer of Moderna, Inc., effective October 5, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: Chief Operating Officer
- Executive departure
Chief Technical Operations and Quality Officer departs: Jerh Collins, Ph.D.
Jerh Collins, Ph.D., Chief Technical Operations and Quality Officer of Moderna, Inc., retires the role. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 30, 2026Role: Chief Technical Operations and Quality Officer
Last verified Nov 8, 2026